Multiple signaling pathways in the frontiers of lung cancer progression
Lung cancer is a prevalent malignant tumor and the leading cause of cancer-related mortality worldwide. LC is a complex respiratory condition that poses significant challenges for both clinicians and researchers. Crucially, dysregulation of molecular signaling pathways is a key message point in LC....
Saved in:
| Main Authors: | Hao Liu, Dujuan Zhou, Yangjing Ou, Shuanghua Chen, Yunzhu Long, Ting Yuan, Yukun Li, Yingzheng Tan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1593793/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR‐1184/IGFBP2 axis
by: Dengke Yang, et al.
Published: (2020-01-01) -
Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity
by: Neda Hedayati, et al.
Published: (2025-05-01) -
Hes1 in malignant tumors: from molecular mechanism to therapeutic potential
by: Liping Zhang, et al.
Published: (2025-07-01) -
Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
by: Nadi Rostami Ravari, et al.
Published: (2025-02-01) -
Oncogene-driven lung cancer in the era of radiogenomics: current evidence and future developments
by: James Ryan, et al.
Published: (2025-08-01)